Opening speaker – Emeritus Prof Kim Oates AM, The University of Sydney
Kim Oates MD DSc MHP FRACP FRCP is Director of Undergraduate Quality and Safety at the Clinical Excellence Commission, Sydney, Australia. He held the Chair of Paediatrics and Child Health at the University of Sydney from 1985 to 1997 and was simultaneously Chair of the Division of Medicine at the Children’s Hospital in Sydney. He was Chief Executive of the Children’s Hospital from 1997 to 2006, a position which strengthened his passion for patient safety. He has written or edited 13 books and has over 300 publications. His clinical interests include child development, behaviour and the problems of abuse and neglect of children. He has received a range of international and national awards for research and for advocacy on behalf of children. His is Emeritus Professor at the University of Sydney where he is involved in a range of projects including developing and teaching in a leadership course for recent medical graduates from Hanoi Medical University.
British Pharmacological Society speaker – Dr Yoon Loke, University of East Anglia, UK
Dr Yoon K Loke is Senior Lecturer in Clinical Pharmacology at the University of East Anglia, and Co-Convenor of the Cochrane Adverse Effects Methods Group. He has extensive experience in conducting systematic reviews of adverse effects, and is the lead author of Chapter 14 in the Cochrane Handbook of Systematic Reviews. His main interests are in assessing harmful effects from drugs such as the proton pump inhibitors, thiazolidinediones, and inhalers for airway disease. He also serves as Deputy Chair of the National Institute of Health Research Health Technology Assessment Pharmaceutics Panel, and European Editor for the British Journal of Clinical Pharmacology. Dr Loke’s main interest is on how systematic review methodology can be used to answer clinically relevant questions on the adverse effects of medication.
APSA speaker – Prof Gregory Peterson, University of Tasmania
As Professor of Pharmacy and Head of School of Pharmacy at the University of Tasmania, Greg has held a personal Chair in Pharmacy at the University of Tasmania since 2000, awarded on the basis of his research and teaching excellence. Greg has led many state and national projects directed at improving the use of medications and patient outcomes in both community and hospital sectors. Greg established and leads an innovative research unit in Improving Medication Outcomes (UMORE; Unit for Medication Outcomes Research and Education). He has more than 150 research papers published in refereed international and national journals, plus more than 150 professional publications, and has been an editor/chapter contributor for 10 books. He is Co-Editor of Blackwell-Wiley’s Journal of Clinical Pharmacy and Therapeutics. He has served as an alternate Director of the National Prescribing Service. He is currently a member of the Australian Government’s Repatriation Pharmaceutical Benefits Committee and the Drug Utilisation Subcommittee, Pharmaceutical Benefits Advisory Committee. Greg is still a practicing pharmacist (working 6 hours each week), accredited consultant pharmacist, and has until recently co-owned a large rural community pharmacy. In 2007 he was awarded the Pharmaceutical Society of Australia’s highest honour – the Australian Pharmacist of the Year.
ASCEPT speaker – Professor Kathie Knights PhD, Flinders University, South Australia
Kathie completed a BSc Honours degree in biochemistry and pharmacology in London while working at Guy’s and Kings College Hospitals. She obtained her PhD from Flinders University in 1984 and a Graduate Certificate in Tertiary Education, 1997. In 1989 she was appointed as a Lecturer in the Department of Clinical Pharmacology at Flinders University and was promoted to Professor in 2008. In 2007 she was awarded an Australian Carrick Citation for outstanding contribution to student learning and in 2010 the ASCEPT Teaching Excellence Award. A member of ASCEPT since 1980 she served as Councillor and Treasurer (1997-2000) and as ASCEPT President (2008-2009). Additionally, she has served as a Councillor (2008-2011) of the International Society for the Study of Xenobiotics (ISSX). Currently she is a member of the BPS, the Drug Metabolism Section of IUPHAR and the National Committee for Biomedical Sciences of the Australian Academy of Science.
The main focus of her research is the enzymology of drug metabolism and in particular the metabolism and renal and cardiovascular toxicity of non-steroidal anti-inflammatory drugs. Other research areas include the inter-relationships between xenobiotic and endobiotic metabolism and the in vitro–in vivo correlation of drugs eliminated by glucuronidation. To date she has published >150 journal articles and abstracts in peer reviewed international journals, five book chapters and is currently a member of the editorial boards of Drug Metabolism Reviews and the British Journal of Clinical Pharmacology. She is co-author of the highly successful text Pharmacology for Health Professionals. In addition to her research Professor Knights is actively involved in the education of health professionals including medical and paramedic students and Nurse Practitioners.
2012 APSA Medalist – Emeritus Prof Andrew Gilbert, University of South Australia
Emeritus Prof Andrew Gilbert is the former director of The Quality Use of Medicines and Pharmacy Research Centre and the 2012 recipient of the APSA medal. Emeritus Prof Gilbert is a pharmacist and leader with an international reputation for his research in areas of medicines policy and health practice change. Translational research is a key focus of Emeritus Prof Gilbert’s research portfolio. His recent research has involved for an analysis of medication-related problems in the community, including a health economic analysis. This program led to Federal funding of Home Medication Reviews for at risk people in the community. He also led to the development and implementation of professional practice standards for the provision of non-prescription medicines through pharmacies. He has had a strong focus of research enhanced outcomes for residents of aged-care facilities through the development and implementation of guidelines for improving medication use in aged-care facilities. Emeritus Prof Gilbert was awarded the Pharmacist of the Year Award in 2005 and in 2011 he was recognized by the Pharmaceutical Society of Australia with a Lifetime Achievement Award for his work in medicines policy development, implementation and evaluation, pharmacoepidemiology and health practice change.